SLC9A9 links tumor immune infiltration to therapeutic response in colorectal cancer with emphasis on mismatch repair proficient subtype.

Cancer Cell Int · 2025 · PMC12849233 · PMID 41454328

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Updated data from this trial demonstrated a favorable trend in overall survival and response even within the pMMR subgroup, although statistical significance was not reached [ 14 ].

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.